Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

3.

A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l.

Koletar SL, Heald AE, Finkelstein D, Hafner R, Currier JS, McCutchan JA, Vallee M, Torriani FJ, Powderly WG, Fass RJ, Murphy RL; ACTG 888 Study Team.

AIDS. 2001 Aug 17;15(12):1509-15.

PMID:
11504983
4.

Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults.

Smith BA, Neidig JL, Nickel JT, Mitchell GL, Para MF, Fass RJ.

AIDS. 2001 Apr 13;15(6):693-701.

PMID:
11371683
5.

Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group.

Hewitt RG, Yiannoutsos CT, Higgs ES, Carey JT, Geiseler PJ, Soave R, Rosenberg R, Vazquez GJ, Wheat LJ, Fass RJ, Antoninievic Z, Walawander AL, Flanigan TP, Bender JF.

Clin Infect Dis. 2000 Oct;31(4):1084-92. Epub 2000 Oct 25.

PMID:
11049793
6.

Social support and unsupportive social interactions: their association with depression among people living with HIV.

Ingram KM, Jones DA, Fass RJ, Neidig JL, Song YS.

AIDS Care. 1999 Jun;11(3):313-29.

PMID:
10474630
7.

In vitro activity of Bay 12-8039, a new 8-methoxyquinolone.

Fass RJ.

Antimicrob Agents Chemother. 1997 Aug;41(8):1818-24.

8.

Inclusion of women in clinical trials of antiretroviral agents for HIV/AIDS during pregnancy.

Mangino JE, Fass RJ.

Lancet. 1997 Jul 12;350(9071):150. No abstract available.

PMID:
9228998
9.

Antibiotic-impregnated cement and beads for orthopedic infections.

Wininger DA, Fass RJ.

Antimicrob Agents Chemother. 1996 Dec;40(12):2675-9. Review. No abstract available.

10.

Candida infections in the surgical intensive care unit.

Fass RJ, Goff DA, Sierawski SJ.

J Antimicrob Chemother. 1996 Nov;38(5):915-6. No abstract available.

PMID:
8961068
12.
13.

Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital.

Fass RJ, Barnishan J, Ayers LW.

J Antimicrob Chemother. 1995 Aug;36(2):343-53.

PMID:
8522464
14.

Revised interpretation of oxacillin MICs for Staphylococcus epidermidis based on mecA detection.

McDonald CL, Maher WE, Fass RJ.

Antimicrob Agents Chemother. 1995 Apr;39(4):982-4.

15.

Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles.

Goff DA, Koletar SL, Buesching WJ, Barnishan J, Fass RJ.

Clin Infect Dis. 1995 Jan;20(1):77-83.

PMID:
7727675
17.

Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection.

Podraza AM, Bornstein RA, Whitacre CC, Para MF, Fass RJ, Rice RR Jr, Nasrallah HA.

J Clin Exp Neuropsychol. 1994 Oct;16(5):777-83.

PMID:
7836501
18.

Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.

Black JR, Feinberg J, Murphy RL, Fass RJ, Finkelstein D, Akil B, Safrin S, Carey JT, Stansell J, Plouffe JF, et al.

Clin Infect Dis. 1994 Jun;18(6):905-13.

PMID:
8086551
19.

The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3.

Fischl MA, Resnick L, Coombs R, Kremer AB, Pottage JC Jr, Fass RJ, Fife KH, Powderly WG, Collier AC, Aspinall RL, et al.

J Acquir Immune Defic Syndr. 1994 Feb;7(2):139-47.

PMID:
7905523
20.

Duration of illness and neuropsychological performance in asymptomatic HIV infection.

Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Fass RJ.

J Neuropsychiatry Clin Neurosci. 1994 Spring;6(2):160-4.

PMID:
8044038
21.

Change in neuropsychological performance in asymptomatic HIV infection: 1-year follow-up.

Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Fass RJ.

AIDS. 1993 Dec;7(12):1607-11.

PMID:
8286070
22.

In vitro activity of Bay y 3118, a new quinolone.

Fass RJ.

Antimicrob Agents Chemother. 1993 Nov;37(11):2348-57.

24.

Aetiology and treatment of community-acquired pneumonia in adults: an historical perspective.

Fass RJ.

J Antimicrob Chemother. 1993 Jul;32 Suppl A:17-27. Review.

PMID:
8407696
25.

Depression and neuropsychological performance in asymptomatic HIV infection.

Bornstein RA, Pace P, Rosenberger P, Nasrallah HA, Para MF, Whitacre CC, Fass RJ.

Am J Psychiatry. 1993 Jun;150(6):922-7.

PMID:
8494070
27.

Psychopathology in human immunodeficiency virus infection: lifetime and current assessment.

Rosenberger PH, Bornstein RA, Nasrallah HA, Para MF, Whitaker CC, Fass RJ, Rice RR Jr.

Compr Psychiatry. 1993 May-Jun;34(3):150-8.

PMID:
8339532
28.

Neuropsychological performance in symptomatic and asymptomatic HIV infection.

Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Rosenberger P, Fass RJ.

AIDS. 1993 Apr;7(4):519-24.

PMID:
8507418
29.

Drug and alcohol use and neuropsychological performance in asymptomatic HIV infection.

Bornstein RA, Fama R, Rosenberger P, Whitacre CC, Para MF, Nasrallah HA, Fass RJ.

J Neuropsychiatry Clin Neurosci. 1993 Summer;5(3):254-9.

PMID:
8369633
30.
31.

Quantitation of antigen-specific immune responses in human immunodeficiency virus (HIV)-infected individuals by limiting dilution analysis.

Sabbaj S, Para MF, Fass RJ, Adams PW, Orosz CG, Whitacre CC.

J Clin Immunol. 1992 May;12(3):216-24.

PMID:
1383258
32.

In vitro activity of DNA gyrase inhibitors, singly and in combination, against Mycobacterium avium complex.

Babinchak TJ, Fass RJ.

Diagn Microbiol Infect Dis. 1992 May-Jun;15(4):367-70.

PMID:
1319302
33.

Neuropsychological performance in asymptomatic HIV infection.

Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Rosenberger P, Fass RJ, Rice R Jr.

J Neuropsychiatry Clin Neurosci. 1992 Fall;4(4):386-94.

PMID:
1358300
34.

Magnetic resonance imaging of white matter lesions in HIV infection.

Bornstein RA, Chakeres D, Brogan M, Nasrallah HA, Fass RJ, Para M, Whitacre C.

J Neuropsychiatry Clin Neurosci. 1992 Spring;4(2):174-8.

PMID:
1627978
35.

Rate of CD4 decline and neuropsychological performance in HIV infection.

Bornstein RA, Nasrallah HA, Para MF, Fass RJ, Whitacre CC, Rice RR Jr.

Arch Neurol. 1991 Jul;48(7):704-7.

PMID:
1677559
36.

Clindamycin and primaquine as primary treatment for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS.

Black JR, Feinberg J, Murphy RL, Fass RJ, Carey J, Sattler FR.

Eur J Clin Microbiol Infect Dis. 1991 Mar;10(3):204-7.

PMID:
2060532
38.

Penicillinase production and in vitro susceptibilities of Staphylococcus lugdunensis.

Herchline TE, Barnishan J, Ayers LW, Fass RJ.

Antimicrob Agents Chemother. 1990 Dec;34(12):2434-5.

39.
40.
41.

In vitro activity of BAY v 3522, a new oral cephalosporin.

Fass RJ.

Antimicrob Agents Chemother. 1990 Sep;34(9):1855-7.

42.

Ciprofloxacin. Best use of this new broad-spectrum antibiotic.

Fass RJ.

Postgrad Med. 1990 Jun;87(8):117-22, 124, 127-31. Review.

PMID:
2189125
43.

Quinolone antibacterial agents for the treatment of genitourinary tract infections.

Babinchak TJ, Fass RJ.

Eur J Clin Microbiol Infect Dis. 1989 Dec;8(12):1111-6. Review.

PMID:
2695332
44.

Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections.

Fass RJ, Plouffe JF, Russell JA.

Am J Med. 1989 Nov 30;87(5A):164S-168S.

PMID:
2589361
45.

Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.

Fass RJ, Prior RB.

Antimicrob Agents Chemother. 1989 Aug;33(8):1268-74.

46.

In vitro activity of cefixime, a new oral cephalosporin.

Fass RJ, Helsel VL.

Chemioterapia. 1988 Dec;7(6):365-8.

PMID:
3219746
47.

In vitro activity of U-76,252 (CS-807), a new oral cephalosporin.

Fass RJ, Helsel VL.

Antimicrob Agents Chemother. 1988 Jul;32(7):1082-5.

48.
49.

Platelet-mediated bleeding caused by broad-spectrum penicillins.

Fass RJ, Copelan EA, Brandt JT, Moeschberger ML, Ashton JJ.

J Infect Dis. 1987 Jun;155(6):1242-8.

PMID:
3572037
50.

Supplemental Content

Support Center